Select Publications
Journal articles
, 2018, 'Structural Evolution of Molybdenum Disulfide Prepared by Atomic Layer Deposition for Realization of Large Scale Films in Microelectronic Applications', ACS Applied Nano Materials, 1, pp. 4028 - 4037, http://dx.doi.org/10.1021/acsanm.8b00798
, 2018, 'Making Sense of SNPs: Women’s Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks', Journal of Genetic Counseling, 27, pp. 702 - 708, http://dx.doi.org/10.1007/s10897-017-0162-z
, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, 18, pp. 389, http://dx.doi.org/10.1186/s12885-018-4366-x
, 2018, 'A comparison of Australian and French families affected by sarcoma: Perceptions of genetics and incidental findings', Personalized Medicine, 15, pp. 13 - 24, http://dx.doi.org/10.2217/pme-2017-0035
, 2018, 'Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership', Journal of Community Genetics, 9, pp. 57 - 64, http://dx.doi.org/10.1007/s12687-017-0323-7
, 2017, 'Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review', Clinical Genetics, 92, pp. 121 - 133, http://dx.doi.org/10.1111/cge.12868
, 2017, 'Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study', BMC Cancer, 17, pp. 491, http://dx.doi.org/10.1186/s12885-017-3485-0
, 2017, 'Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?', Familial Cancer, 16, pp. 423 - 432, http://dx.doi.org/10.1007/s10689-016-9964-7
, 2016, 'Monogenic and polygenic determinants of sarcoma risk: an international genetic study', The Lancet Oncology, 17, pp. 1261 - 1271, http://dx.doi.org/10.1016/S1470-2045(16)30147-4
, 2016, 'Clinically significant germline mutations in cancer-causing genes identified through research studies should be offered to research participants by genetic counselors', Journal of Clinical Oncology, 34, pp. 898 - 901, http://dx.doi.org/10.1200/JCO.2015.60.9388
, 2016, 'Timing and context: important considerations in the return of genetic results to research participants', Journal of Community Genetics, 7, pp. 11 - 20, http://dx.doi.org/10.1007/s12687-015-0231-7
, 2015, 'Implementing a telephone based peer support intervention for women with a BRCA1/2 mutation', Familial Cancer, 14, pp. 373 - 382, http://dx.doi.org/10.1007/s10689-015-9797-9
, 2015, 'Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features', Familial Cancer, 14, pp. 287 - 295, http://dx.doi.org/10.1007/s10689-015-9785-0
, 2015, 'Connecting patients, researchers and clinical genetics services: The experiences of participants in the Australian ovarian cancer study (AOCS)', European Journal of Human Genetics, 23, pp. 152 - 158, http://dx.doi.org/10.1038/ejhg.2014.86
, 2014, 'Randomized controlled trial of a telephone-based peer-support program for women carrying a BRCA1 or BRCA2 mutation: Impact on psychological distress', Journal of Clinical Oncology, 32, pp. 4073 - 4080, http://dx.doi.org/10.1200/JCO.2013.54.1607
, 2014, 'CAN PEER SUPPORT PROGRAM FOR FEMALE BRCA1 OR BRCA2 MUTATION CARRIERS REDUCE DISTRESS? FINDINGS FROM A RANDOMIZED CONTROLLED TRIAL', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 256 - 256, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700778&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'CONSUMER EXPERIENCE OF A TELEPHONE BASED PEER SUPPORT INTERVENTION FOR WOMEN WITH A BRCA1/2 MUTATION', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Unmet support needs and distress among women with a BRCA1/2 mutation', Familial Cancer, 12, pp. 509 - 518, http://dx.doi.org/10.1007/s10689-012-9596-5
, 2013, 'Cited1 Deficiency Suppresses Intestinal Tumorigenesis', PLoS Genetics, 9, http://dx.doi.org/10.1371/journal.pgen.1003638
, 2013, 'Tricky teens: Are they really tricky or do genetic health professionals simply require more training in adolescent health?', Personalized Medicine, 10, pp. 589 - 600, http://dx.doi.org/10.2217/pme.13.49
, 2013, 'High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0069026
, 2013, 'The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study', Genetics in Medicine, 15, pp. 458 - 465, http://dx.doi.org/10.1038/gim.2012.154
, 2013, 'The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research', Clinical Sarcoma Research, 3, pp. 11 - 11, http://dx.doi.org/10.1186/2045-3329-3-11
, 2012, 'The consequences of risk reducing salpingo-oophorectomy: The case for a coordinated approach to long-term follow up post surgical menopause', Familial Cancer, 11, pp. 403 - 410, http://dx.doi.org/10.1007/s10689-012-9527-5
, 2012, 'Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London', Familial Cancer, 11, pp. 107 - 113, http://dx.doi.org/10.1007/s10689-011-9482-6
, 2012, 'An audit of treatment focussed BRCA1/2 mutation testing at an integrated Familial Cancer Clinic', Hereditary Cancer in Clinical Practice, 10, pp. A49 - A49, http://dx.doi.org/10.1186/1897-4287-10-s2-a49
, 2012, 'Role of oncology/genetics nurse in management of individuals with hereditary diffuse gastric cancer', Hereditary Cancer in Clinical Practice, 10, pp. A70 - A70, http://dx.doi.org/10.1186/1897-4287-10-s2-a70
, 2012, 'The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort', Hereditary Cancer in Clinical Practice, 10, pp. A89 - A89, http://dx.doi.org/10.1186/1897-4287-10-s2-a89
, 2012, 'The experiences of research participants offered genetic test results as a result of taking part in a population based ovarian cancer research study?', Hereditary Cancer in Clinical Practice, 10, pp. A15 - A15, http://dx.doi.org/10.1186/1897-4287-10-s2-a15
, 2011, 'Ethical Tensions in Genetic Counselling Research', Monash Bioethics Review, 29, pp. 31 - 42, http://dx.doi.org/10.1007/BF03351326
, 2009, 'Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications?', Medical Journal of Australia, 191, pp. 255 - 258
, 2008, 'G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: Evaluation of its pathogenicity and inferences on its genealogical history', Breast Cancer Research and Treatment, 110, pp. 377 - 385, http://dx.doi.org/10.1007/s10549-007-9729-y
, 2008, 'A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk', Breast Cancer Research and Treatment, 107, pp. 289 - 301, http://dx.doi.org/10.1007/s10549-007-9539-2
, 2008, 'A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling', Psycho - Oncology, 17, pp. 844 - 854
, 2008, 'Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk', Cancer, 113, pp. 956 - 965
, 2007, 'Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer', Familial Cancer, 6, pp. 301 - 310, http://dx.doi.org/10.1007/s10689-007-9124-1
, 2007, 'Health beliefs and behaviors of women who have received genetic counseling for breast cancer', Journal of Genetic Counseling, 16, pp. 457 - 468, http://dx.doi.org/10.1007/s10897-006-9079-7
, 2007, 'Genome-wide association study identifies novel breast cancer susceptibility loci', Nature, 447, pp. 1087 - 1093, http://dx.doi.org/10.1038/nature05887
, 2006, 'Screening behavior in women at increased familial risk for breast cancer', Familial Cancer, 5, pp. 359 - 368, http://dx.doi.org/10.1007/s10689-006-0006-8
, 2006, 'In reply [6]', Journal of Clinical Oncology, 24, pp. 3311 - 3312, http://dx.doi.org/10.1200/JCO.2006.06.7017
, 2006, 'A qualitative study of health professionals' views regarding provision of information about health-protective behaviors during genetic consultation for breast cancer', Journal of Genetic Counseling, 15, pp. 95 - 104, http://dx.doi.org/10.1007/s10897-005-9009-0
, 2006, 'Optimal selection of individuals for BRCA mutation testing: A comparison of available methods', Journal of Clinical Oncology, 24, pp. 707 - 715, http://dx.doi.org/10.1200/JCO.2005.01.9737
, 2006, 'Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer', European Journal of Cancer, 42, pp. 621 - 628
, 2005, 'Educating genetic counselors in Australia: Developing an international perspective', Journal of Genetic Counseling, 14, pp. 283 - 294, http://dx.doi.org/10.1007/s10897-005-0572-1
, 2005, 'Genetic professionals' reports of nondisclosure of genetic risk information within families', European Journal of Human Genetics, 13, pp. 556 - 562, http://dx.doi.org/10.1038/sj.ejhg.5201394
, 2005, 'Supportive‐expressive group therapy for women with brca1/2mutations: Results of a phase II trial', Nursing & Health Sciences, 7, pp. 146 - 146, http://dx.doi.org/10.1111/j.1442-2018.2005.00233_12.x
, 2004, 'Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study', Cancer Epidemiology Biomarkers and Prevention, 13, pp. 2258 - 2263
, 2004, 'A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations', Cancer, 101, pp. 2327 - 2340, http://dx.doi.org/10.1002/cncr.20661
, 2004, 'Optimal selection of individuals for BRCA1 and BRCA2 gene testing', Journal of Clinical Oncology, 22, pp. 1009 - 1009, http://dx.doi.org/10.1200/jco.2004.22.90140.1009
, 2004, 'Optimal selection of individuals for BRCA1 and BRCA2 gene testing', Journal of Clinical Oncology, 22, pp. 1009 - 1009, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.1009